Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Hyperfine Community
NasdaqGM:HYPR Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
Hyperfine
Popular
Undervalued
Overvalued
Community Investing Ideas
Hyperfine
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
2025 Swoop Software Releases Will Boost Healthcare Imaging Adoption
Key Takeaways Launching AI-powered software and expanding into neurology offices will likely enhance market penetration and diversify revenue streams. Improved operational efficiency and strategic international expansion position Hyperfine for stable, long-term earnings growth.
View narrative
US$1.30
FV
41.7% undervalued
intrinsic discount
20.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
HYPR
HYPR
Hyperfine
Your Fair Value
US$
Current Price
US$0.76
11.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-73m
29m
2015
2018
2021
2024
2025
2027
2030
Revenue US$29.3m
Earnings US$4.3m
Advanced
Set Fair Value